Allopurinol for women in pregnancy for neuroprotection of the fetus

Martinello, KA; Shepherd, E; Middleton, P; Crowther, Caroline

dc.contributor.author	Martinello, KA	en
dc.contributor.author	Shepherd, E	en
dc.contributor.author	Middleton, P	en
dc.contributor.author	Crowther, Caroline	en
dc.date.accessioned	2018-10-19T02:34:49Z	en
dc.date.issued	2017-12-12	en
dc.identifier.citation	Cochrane Database of Systematic Reviews 2017(12) 12 Dec 2017	en
dc.identifier.uri	http://hdl.handle.net/2292/42977	en
dc.description.abstract	© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of maternal allopurinol when used for neuroprotection of the fetus.	en
dc.relation.ispartofseries	Cochrane Database of Systematic Reviews	en
dc.rights	Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.	en
dc.rights.uri	https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm	en
dc.rights.uri	https://www.cochranelibrary.com/about/open-access	en
dc.title	Allopurinol for women in pregnancy for neuroprotection of the fetus	en
dc.type	Journal Article	en
dc.identifier.doi	10.1002/14651858.CD012881	en
pubs.issue	12	en
pubs.volume	2017	en
dc.rights.holder	Copyright: The authors	en
pubs.publication-status	Published	en
dc.rights.accessrights	http://purl.org/eprint/accessRights/OpenAccess	en
pubs.subtype	Journal Article	en
pubs.elements-id	719560	en
pubs.org-id	Liggins Institute	en
pubs.org-id	LiFePATH	en
dc.identifier.eissn	1469-493X	en